<VariationArchive VariationID="1803172" VariationName="NM_004656.4(BAP1):c.206del (p.Thr69fs)" VariationType="Deletion" Accession="VCV001803172" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1860201" VariationID="1803172">
      <GeneList>
        <Gene Symbol="BAP1" FullName="BRCA1 associated deubiquitinase 1" GeneID="8314" HGNC_ID="HGNC:950" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52401008" stop="52410008" display_start="52401008" display_stop="52410008" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52435023" stop="52444008" display_start="52435023" display_stop="52444008" Strand="-" />
          </Location>
          <OMIM>603089</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004656.4(BAP1):c.206del (p.Thr69fs)</Name>
      <CanonicalSPDI>NC_000003.12:52408522:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52408523" stop="52408523" display_start="52408523" display_stop="52408523" variantLength="1" positionVCF="52408522" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52442539" stop="52442539" display_start="52442539" display_stop="52442539" variantLength="1" positionVCF="52442538" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T69fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.52442539del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.52442539del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.52408523del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.52408523del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031859.1" sequenceAccession="NG_031859" sequenceVersion="1" change="g.6471del">
            <Expression>NG_031859.1:g.6471del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410772.1" sequenceAccession="NM_001410772" sequenceVersion="1" change="c.206delC">
            <Expression>NM_001410772.1:c.206delC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397701.1" sequenceAccession="NP_001397701" sequenceVersion="1" change="p.Thr69Serfs">
            <Expression>NP_001397701.1:p.Thr69Serfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004656.4" sequenceAccession="NM_004656" sequenceVersion="4" change="c.206del" MANESelect="true">
            <Expression>NM_004656.4:c.206del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004647.1" sequenceAccession="NP_004647" sequenceVersion="1" change="p.Thr69fs">
            <Expression>NP_004647.1:p.Thr69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004656.4" sequenceAccession="NM_004656" sequenceVersion="4" change="c.206delC" MANESelect="true">
            <Expression>NM_004656.4:c.206delC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_529" sequenceAccession="LRG_529">
            <Expression>LRG_529:g.6471del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_529t1" sequenceAccession="LRG_529t1">
            <Expression>LRG_529t1:c.206del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_529p1" sequenceAccession="LRG_529p1" change="p.Thr69Serfs">
            <Expression>LRG_529p1:p.Thr69Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004656.4(BAP1):c.206del (p.Thr69fs) AND BAP1-related tumor predisposition syndrome" Accession="RCV002466842" Version="1">
        <ClassifiedConditionList TraitSetID="7637">
          <ClassifiedCondition DB="MedGen" ID="C3280492">BAP1-related tumor predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21874000</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30517737</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7637" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16619" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">BAP1-related tumor predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0013692" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BAP1 tumor predisposition syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COMMON Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition syndrome</ElementValue>
                <XRef ID="TUMOR+PREDISPOSITION+SYNDROME/9432" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor susceptibility linked to germline BAP1 mutations</ElementValue>
                <XRef ID="289539" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TPDS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TPDS1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for a specific skin lesion, BAP1-inactivated melanocytic tumors (BIMT; formerly called atypical Spitz tumors), and the following cancers, in descending order of frequency: uveal (eye) melanoma (UM), malignant mesothelioma (MMe), cutaneous melanoma (CM), renal cell carcinoma (RCC), and basal cell carcinoma (BCC). Hepatocellular carcinoma, cholangiocarcinoma, and meningioma may also be associated with BAP1-TPDS. Affected individuals can have more than one type of primary cancer. In general, the median age of onset of these tumors is younger than in the general population. UM tends to be a more aggressive class 2 tumor with higher risk for metastasis and reduced survival compared to UM occurring in the general population. Due to the limited number of families reported to date, the penetrance, natural history, and frequencies of BAP1-associated tumors are yet to be determined. Other suspected but unconfirmed tumors in BAP1-TPDS include (in alphabetic order): breast cancer, neuroendocrine carcinoma, non-small-cell lung adenocarcinoma, thyroid cancer, and urinary bladder cancer.</Attribute>
                <XRef ID="NBK390611" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13219" />
                <XRef ID="13219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27748099</ID>
                <ID Source="BookShelf">NBK390611</ID>
              </Citation>
              <XRef ID="289539" DB="Orphanet" />
              <XRef ID="C3280492" DB="MedGen" />
              <XRef ID="MONDO:0013692" DB="MONDO" />
              <XRef Type="MIM" ID="614327" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5403426" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/familial_cancer_frome_rd/vc13175" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002761614" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21874000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30517737</ID>
          </Citation>
          <Comment>PM2: NA in gnomad, Exac, Clinvar, cosmid PP4: variant associated with PHx and FHx phylop:2.6 (&gt;2 potentially pathogenic), GERP:5.52(conserved) --&gt; PP3 PVS1: null variant PS3: multiple cases of null variants has shown aberrant transcript and lack of BAP1 nuclear expression in renal cell carcinoma (Walpole S et al. 2018_BAP1_PMID 30517737) and BAP1 associated tumour, malignant mesothelioma (Testa JR et al 2011_PMID21874000_BAP1)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_384</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.4:c.206delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0013692" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_37</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5403426" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0013692" MappingRef="MONDO">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

